Beyond Air (NASDAQ:XAIR) is a clinical-stage medical technology company focused on the development and commercialization of inhaled nitric oxide (NO) therapy for pulmonary and respiratory diseases. The company’s proprietary LungFit® platform delivers pulsed, low-dose nitric oxide gas through compact, portable devices designed to support treatments in both inpatient and outpatient settings. Beyond Air’s approach leverages NO’s antimicrobial, vasodilatory and anti-inflammatory properties to address a range of unmet needs in respiratory medicine.
The company’s lead candidate, LungFit® PH, is under investigation for the treatment of pulmonary hypertension, with ongoing clinical studies assessing its impact on pulmonary arterial pressure and exercise capacity. Beyond Air is also evaluating LungFit® PT for pulmonary tuberculosis and LungFit® C for viral and bacterial lung infections, including potential applications in acute respiratory distress syndrome. These programs position the LungFit platform as a versatile therapy that may complement or improve upon existing treatment options.
Beyond Air operates primarily in the United States and collaborates with academic and clinical research centers to advance its clinical trials. The company engages with regulatory authorities, including the U.S. Food and Drug Administration, to pursue marketing approvals and expanded indications for its nitric oxide therapies. By building strategic partnerships, Beyond Air aims to broaden access to its platform technology across diverse healthcare markets.
Founded in 2013 and headquartered in East Setauket, New York, Beyond Air is led by President and Chief Executive Officer Nicholas E. Caputo, a life sciences executive with extensive experience in medical device development and regulatory strategy. Under his leadership, the company has advanced multiple product candidates through early-stage clinical evaluation and continues to build a pipeline of inhaled gas therapies designed to improve outcomes for patients with challenging respiratory conditions.
